ALX-009

Bactericidal combination of bovine lactoferrin and hypothiocyanite

Phase of research

Phase One Clinical Trial

How it helps

Anti-Infective

General information

ALX-009 is a substance used in experimental studies and not yet available as a human pharmaceutical. It is a combination of hypothiocyanite and lactoferrin with antimicrobial properties. In relation to cystic fibrosis, our AIM tool found the data that ALX-009 helps against Pseudomonas aeruginosa infection.

ALX-009

Synonyms

N/A

Marketed as

N/A

Dietary sources

N/A

Structure image not available

N/A

Drug-Mutation Relation

results for 120del23 / 2869insG

See all data on ALX-009

Treats

Mutation	Link	Tested on	Impact factor	Notes
General effect	Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum.	humans	5.11

Does not treat

Mutation	Link	Tested on	Impact factor	Notes